Professor O’Neill holds the Chair of Biochemistry at Trinity College Dublin where he leads the Inflammation Research Group.
He has a Ph.D. in Pharmacology from the University of London and carried out Post-Doctoral research at Cambridge U.K.
His research is in the area of the molecular basis to inflammatory diseases.
In 2017 he was named one of the world’s most influential scientists by Clarivates Analytics.
He is a co-founder of two Spin-out companies — Opsona Therapeutics and Inflazome Ltd, which are developing new treatments for inflammatory diseases.
He was elected a Fellow of the Royal Society in 2016.